GlassScriptPhysician profile
Clay C Guynn
NPI 1699180398
$192,745.53
in general payments reported to CMS, 2019-2025
24 companies · $75K in 2025
The $75K reported for 2025 was more than what 99% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $197 · 2021: $409 · 2022: $1,192 · 2023: $27K · 2024: $89K · 2025: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $118K · Travel and Lodging: $36K · Honoraria: $26K · Food and Beverage: $12K · Education: $10.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $117,530.94 |
| Travel and Lodging | $35,512.41 |
| Honoraria | $25,990.00 |
| Food and Beverage | $11,743.99 |
| Education | $10.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $190,284.61 | 2020-2025 | Iovera, Zilretta, Exparel |
| Abbvie INC. | $364.39 | 2022-2025 | |
| Horizon Therapeutics Plc | $354.13 | 2019-2022 | |
| Linkbio Corp | $271.38 | 2024 | |
| Bioventus LLC | $261.20 | 2021-2025 | Xcell, Exogen Ultrasound Bone Healing System, Durolane |
| Avanos Medical | $228.28 | 2019-2025 | Coolief Cooled Radiofrequency |
| Pacira Therapeutics, INC. | $216.79 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $147.71 | 2024-2025 | |
| Abbott Laboratories | $133.89 | 2021-2025 | Eterna |
| Averitas Pharma INC. | $67.57 | 2024 | Qutenza |
| Ipsen Biopharmaceuticals, INC | $60.91 | 2022-2023 | Dysport |
| Allergan, INC. | $54.51 | 2021-2022 | |
| Hydrocision, INC. | $52.30 | 2023 | Tenjet |
| Spr Therapeutics, INC | $49.46 | 2022-2023 | Sprint Pns System |
| United Orthopedics LLC | $32.44 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $24.62 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Innovation Technologies INC | $22.68 | 2024 | Irrisept |
| Radius Health, INC. | $20.74 | 2022 | |
| Sanara Medtech INC. | $20.17 | 2024 | Celleraterx |
| Grt US Holding, INC. | $17.41 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.01 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.99 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $13.95 | 2022 | |
| Assertio Therapeutics, INC. | $13.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clay Guynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.